Emmessar Biotech & Nutrition Limited
BSE: EMMESSA
Prev Close
28.67
Open Price
29.34
Volume
572
Today Low / High
27.31 / 29.34
52 WK Low / High
27 / 47.19
Range
27 - 30
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 28.89, reflecting a change of 0.22 (0.76735%). The expected target range on the BSE is 27 - 30. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Emmessar Biotech & Nutrition Limited Graph
Emmessar Biotech & Nutrition Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Emmessar Biotech & Nutrition Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 28.89, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 28.89 | 29.18 | 26.26 - 32.10 |
| 29.47 | 23.57 - 35.36 | ||
| 29.76 | 20.83 - 38.68 | ||
| Bearish Scenario | 28.89 | 28.60 | 25.74 - 31.46 |
| 28.31 | 22.65 - 33.97 | ||
| 28.02 | 19.62 - 36.43 |
Overview of Emmessar Biotech & Nutrition Limited
ISIN
INE634B01016
Industry
Medical - Pharmaceuticals
Vol.Avg
3,188
Market Cap
144,337,329
Last Dividend
0
Official Website
IPO Date
DCF Diff
-50.30
DCF
79
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.62 Cr | 0.18 Cr | 2.44 Cr | 0.9306 | 0.00 Cr | 0.00 Cr | 0.96 Cr | 0.32 Cr | 0.61 | 1.06 Cr | 0.1207 |
| 2024-03-31 | 0.56 Cr | 1.30 Cr | -0.74 Cr | -1.3392 | 0.00 Cr | 0.14 Cr | -1.18 Cr | 0.75 Cr | 1.48 | -1.08 Cr | 1.3504 |
| 2023-03-31 | 1.02 Cr | 0.40 Cr | 0.62 Cr | 0.6077 | 0.00 Cr | 0.10 Cr | -0.77 Cr | 0.50 Cr | 1.01 | -0.69 Cr | 0.4943 |
| 2022-03-31 | 0.36 Cr | 0.13 Cr | 0.24 Cr | 0.6558 | 0.00 Cr | 0.10 Cr | -0.95 Cr | 0.48 Cr | 0.95 | -1.07 Cr | 1.3028 |
| 2021-03-31 | 6.99 Cr | 3.53 Cr | 3.46 Cr | 0.4947 | 0.00 Cr | 0.06 Cr | 0.79 Cr | 1.45 Cr | 2.90 | 0.85 Cr | 0.2074 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.87 Cr | 9.22 Cr | 1.51 Cr | 7.7080 Cr | 0.00 Cr | -6.87 Cr | 0.12 Cr | 1.22 Cr | 0.00 Cr | 0.00 Cr | 0.59 Cr | 0.4725 Cr |
| 2024-03-31 | 0.01 Cr | 8.74 Cr | 1.34 Cr | 7.4024 Cr | 0.11 Cr | 0.10 Cr | 0.09 Cr | 1.31 Cr | 0.00 Cr | 0.00 Cr | 0.60 Cr | 0.5039 Cr |
| 2023-03-31 | 0.01 Cr | 7.94 Cr | 1.28 Cr | 6.6646 Cr | 0.08 Cr | 0.07 Cr | 0.14 Cr | 1.40 Cr | 0.00 Cr | 0.61 Cr | 0.61 Cr | 0.4195 Cr |
| 2022-03-31 | 0.18 Cr | 7.21 Cr | 1.04 Cr | 6.1689 Cr | 0.00 Cr | -0.18 Cr | 0.07 Cr | 1.45 Cr | 0.01 Cr | 0.61 Cr | 0.62 Cr | 0.3301 Cr |
| 2021-03-31 | 0.53 Cr | 7.81 Cr | 2.11 Cr | 5.7008 Cr | 0.00 Cr | -0.53 Cr | 0.07 Cr | 1.23 Cr | 0.01 Cr | 0.00 Cr | 0.63 Cr | 1.4025 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.2238 Cr | -0.2298 Cr | 0.0035 Cr | 0.2238 Cr | -0.0024 Cr | 0.0105 Cr | 0.0000 Cr | 0.3161 Cr | -0.1171 Cr | 0.0000 Cr | -0.0346 Cr |
| 2024-03-31 | 0.6446 Cr | -0.6435 Cr | 0.0000 Cr | 0.6446 Cr | 0.0011 Cr | 0.0129 Cr | 0.0000 Cr | 0.8126 Cr | 0.0326 Cr | 0.0000 Cr | 0.0471 Cr |
| 2023-03-31 | 0.3762 Cr | -0.5463 Cr | 0.0000 Cr | 0.3499 Cr | -0.1701 Cr | 0.0118 Cr | -0.0263 Cr | 0.9669 Cr | 0.0000 Cr | 0.0000 Cr | -0.0680 Cr |
| 2022-03-31 | 2.2698 Cr | -2.6144 Cr | 0.0000 Cr | 1.9642 Cr | -0.3445 Cr | 0.1819 Cr | -0.3056 Cr | 0.9315 Cr | 0.0000 Cr | 0.0000 Cr | -0.0009 Cr |
| 2021-03-31 | 0.4679 Cr | 0.0082 Cr | 0.0000 Cr | 0.4661 Cr | 0.4760 Cr | 0.5264 Cr | -0.0018 Cr | 2.2545 Cr | 0.0000 Cr | 0.0000 Cr | 1.0818 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.70 Cr | 0.03 Cr | 0.67 Cr | 0.9540 | -0.35 Cr | -0.07 Cr | -0.16 | 0.28 Cr | -0.0975 |
| 2024-12-31 | 0.10 Cr | 0.03 Cr | 0.06 Cr | 0.6656 | -0.30 Cr | 0.02 Cr | 0.03 | -0.28 Cr | 0.1792 |
| 2024-09-30 | 0.34 Cr | 0.13 Cr | 0.21 Cr | 0.6246 | -0.10 Cr | 0.28 Cr | 0.56 | -0.08 Cr | 0.8197 |
| 2024-06-30 | 0.08 Cr | 0.28 Cr | -0.20 Cr | -2.5354 | -0.30 Cr | 0.09 Cr | 0.18 | -0.27 Cr | 1.1237 |
| 2024-03-31 | 0.08 Cr | 0.29 Cr | -0.21 Cr | -2.8393 | -0.42 Cr | 0.37 Cr | 0.71 | -0.39 Cr | 4.8938 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.87 Cr | 0.01 Cr | 6.88 Cr | 0.02 Cr | 0.12 Cr | 7.41 Cr | 1.22 Cr | 9.22 Cr | 1.51 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 6.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -7.77 Cr |
| 2024-09-30 | 0.11 Cr | 6.77 Cr | 6.89 Cr | 0.10 Cr | 0.11 Cr | 7.42 Cr | 1.26 Cr | 9.29 Cr | 1.52 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 6.19 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -7.40 Cr |
| 2024-03-31 | 6.18 Cr | 0.01 Cr | 6.19 Cr | 0.29 Cr | 0.09 Cr | 6.83 Cr | 1.31 Cr | 8.74 Cr | 1.34 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born: 1948
Gender: male
Year Born: 1961
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about Emmessar Biotech & Nutrition Limited
The CEO is Mathurakavi Srinivasa Raghavan Ayyangar.
The current price is ₹28.89.
The range is ₹27-47.19.
The market capitalization is ₹14.43 crores.
The P/E ratio is 39.18.
The company operates in the Healthcare sector.
Overview of Emmessar Biotech & Nutrition Limited (ISIN: INE634B01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹14.43 crores and an average daily volume of 3,188 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.